Evidence map›Paper›PMID 34360909›Full record

ReviewInternational journal of molecular sciences2021

The Role of PERK in Understanding Development of Neurodegenerative Diseases.

Garrett Dalton Smedley, Keenan E Walker, Shauna H Yuan

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Endoplasmic reticulum's role in multiple sclerosis, exploring potential biomarkers, and pioneering therapeutic strategies: a comprehensive review of literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. C-phycoerythrin fromMarine drugs · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Garrett Dalton SmedleyDepartment of Neurology, University of Minnesota, Twin Cities, Minneapolis, MN 55455, USA.ORCID 0000-0001-7478-9225
Keenan E WalkerDepartment of Neurology, University of Minnesota, Twin Cities, Minneapolis, MN 55455, USA.ORCID 0000-0002-7282-5920
Shauna H YuanDepartment of Neurology, University of Minnesota, Twin Cities, Minneapolis, MN 55455, USA.ORCID 0000-0003-4058-4146
University of Minnesota · US

Funding

Development of isogenic iPSC cell lines expressing tauopathy-related PERK risk variants to study homeostatic control of protein levels during ER stressR03AG070415 · NIA · UNIVERSITY OF MINNESOTA · PI YUAN, SHAUNA H · 2021 to 2022
$310k
NIA NIH HHS R03 AG070415NIH HHS 1 R03 AG070415-01
6 · The paper itself

Abstract

Neurodegenerative diseases are an ever-increasing problem for the rapidly aging population. Despite this, our understanding of how these neurodegenerative diseases develop and progress, is in most cases, rudimentary. Protein kinase RNA (PKR)-like ER kinase (PERK) comprises one of three unfolded protein response pathways in which cells attempt to manage cellular stress. However, because of its role in the cellular stress response and the far-reaching implications of this pathway, error within the PERK pathway has been shown to lead to a variety of pathologies. Genetic and clinical studies show a correlation between failure of the PERK pathway in neural cells and the development of neurodegeneration, but the wide array of methodology of these studies is presenting conflicting narratives about the role of PERK in these affected systems. Because of the connection between PERK and pathology, PERK has become a high value target of study for understanding neurodegenerative diseases and potentially how to treat them. Here, we present a review of the literature indexed in PubMed of the PERK pathway and some of the complexities involved in investigating the protein's role in the development of neurodegenerative diseases as well as how it may act as a target for therapeutics.

Indexed as

AgedAgingAnimalsDisease Models, AnimaleIF-2 KinaseEndoplasmic ReticulumEndoplasmic Reticulum StressHumansMolecular Targeted TherapyNeurodegenerative DiseasesPolymorphism, Single NucleotideSignal TransductionUnfolded Protein ResponseEIF2AK3 protein, humaneIF-2 Kinaseendoplasmic reticulum stressneurodegenerationPERKtauopathytherapyunfolded protein response

Identifiers

PMID34360909
PMCPMC8348817
OpenAlexW3186397856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.